BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Day In Review: MGI PHARMA, INC. (MOGN) Sells Ex-US Dacogen Rights


7/6/2006 5:19:02 PM

July 6, 2006 -- MGI Pharma out-licensed the ex-US rights for Dacogen, its treatment for myelodysplastic syndrome, to Cilag GmbH; SuperGen will receive half of the $10 million upfront payment from the MGI-Cilag agreement; King will assume full marketing responsibility for its ACE inhibitor, Altace, from Wyeth; Alnylam conflated two RNAi agreements with Merck into one with potential milestones of $120 million; MedImmune received FDA permission to use reverse genetics technology to produce flu vaccines; ISTA Pharma filed for approval of T-Pred, a treatment for eye inflammation and infection; Abbott signed an siRNA deal with Dharmacon; and Elan licensed its NanoCrystal technology to Abbott Labs. The Centient Biotech 200™ added on 27 points, closing at 3679.65, a gain of .74%. More details...

Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES